MTRX Pharmaceutical
Partnering

Licensing, co-development and strategic commercialization.

MTRX is available for partner-led development, regional commercialization, platform licensing, clinical-test-article generation and strategic acquisition discussions.

Collaboration pathways.

Co-development

Asset-specific programs

Apply MTRX to a partner-selected lipophilic active, cannabinoid or botanical molecule.

Licensing

Platform access

License MTRX technology for defined territories, product categories or active classes.

Strategic

Acquisition or investment

Explore broader strategic transactions for the MTRX platform, IP and development package.

Partner profiles.

Pharma

Reformulation, lifecycle and clinical-test-article opportunities for lipophilic assets.

Medical cannabis

Differentiated oral and topical cannabinoid platforms beyond oils and commodity formats.

Dermatology

Topical CBD and lipophilic-active formats for dermatology-oriented development.

Regional partners

Territory-specific commercialization across EU, LATAM and other markets.

Open a controlled technical review.

Initial discussions can proceed using a public summary, followed by NDA-controlled access to technical dossiers, pipeline details and platform data.

Contact MTRX